(Q53123281)

11 May 2018

meta-analysis

0 references

title

Association of rheumatoid arthritis risk alleles with response to anti-TNF biologics: results from the CORRONA registry and meta-analysis. (English)

1 reference

11 May 2018

0 references

0 references

1 reference

Dimitrios A Pappas

1

1 reference

11 May 2018

Cheongeun Oh

2

1 reference

11 May 2018

Robert M Plenge

3

1 reference

11 May 2018

Joel M Kremer

4

1 reference

11 May 2018

Jeffrey D Greenberg

5

1 reference

11 May 2018

publication date

1 April 2013

1 reference

11 May 2018

published in

Inflammation

1 reference

11 May 2018

volume

36

1 reference

11 May 2018

issue

2

1 reference

11 May 2018

page(s)

279-284

1 reference

11 May 2018

The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

21 January 2018

The CORRONA database.

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

Common variants at CD40 and other loci confer risk of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

Meta-analysis: formulating, evaluating, combining, and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

Recent progress in rheumatoid arthritis genetics: one step towards improved patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9544-4

On the operational characteristics of the Benjamini and Hochberg False Discovery Rate procedure

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23007924

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23007924

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10753-012-9544-4

1 reference

11 May 2018

1 reference

11 May 2018